ロード中...
Sensitivity, specificity, inclusivity and exclusivity of the updated Aptima Combo 2 assay, which provides detection coverage of the new diagnostic-escape Chlamydia trachomatis variants
Abstract Background Four new variants of Chlamydia trachomatis (nvCTs), detected in several countries, cause false-negative or equivocal results using the Aptima Combo 2 assay (AC2; Hologic). We evaluated the clinical sensitivity and specificity, as well as the analytical inclusivity and exclusivity...
保存先:
主要な著者: | , , , , , , , , , , , , |
---|---|
フォーマット: | Artigo |
言語: | Inglês |
出版事項: |
BMC
2020-06-01
|
シリーズ: | BMC Infectious Diseases |
主題: | |
オンライン・アクセス: | http://link.springer.com/article/10.1186/s12879-020-05148-7 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|